Paul Anderson, NMD - Immune Therapies for Multiple Sclerosis (2017 Conference) (LDN, low dose naltrexone)

 

Paul Anderson, NMD - Immune Therapies for Multiple Sclerosis (2017 Conference) (LDN, low dose naltrexone)

How LDN can be so successful in treating Multiple Sclerosis (MS) by boosting the immune system and improving the overall wellbeing of the patient.

Dr Paul Anderson started 40 years ago working in medical labs and eventually started up his own lab. Bored with this, he sold the business to go back to school and become an MD. 

He learned about Low Dose Naltrexone (LDN) approximately 15 years ago and treats his patients with a synergetic approach. He finds that LDN is his first line of treatment, but it is accompanied by diet, exercise, and lifestyle changes. Vitamins, supplements and herbs are utilized as an important part of treatment.

In this presentation, Dr Anderson explains how LDN can be so successful in treating Multiple Sclerosis (MS) by boosting the immune system and improving the overall wellbeing of the patient.

This is a summary of Dr Paul Anderson’s presentation. Please listen to the rest of Dr Anderson’s presentation by clicking on the video above